🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Multiple Locations
Start Date
2003-03
Trial ID
NCT01327859
Treatments Being Tested
The study hypothesizes that donepezil will have a positive impact on brain ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01082965
The primary purpose of the study is to determine the safety and tolerabilit...
Status
Completed
Location
Research Site
Start Date
2009-12
Trial ID
NCT01039701
The overall purpose of this research is to determine if there is a relation...
Status
Completed
Location
Multiple Locations
Start Date
2004-11
Trial ID
NCT00768261
Treatments Being Tested
The goal of this clinical trial is to evaluate if phenserine can treat earl...
Status
Completed
Location
Stavanger University Hospital
Start Date
2025-02-01
Trial ID
NCT06774261
Treatments Being Tested
To document effectiveness, safety, and tolerability of donepezil in patient...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2005-06
Trial ID
NCT00174382
Treatments Being Tested
The purpose of this study is to assess the effect of a single oral dose of ...
Status
Terminated
Location
Multiple Locations
Start Date
2016-11-21
Trial ID
NCT02918266
Treatments Being Tested
This study is designed to look at the potential for an investigational drug...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2011-05
Trial ID
NCT01345864
A study to assess the steady-state bioequivalence of once-weekly Corplex™ D...
Status
Completed
Location
Celerion Inc.
Start Date
2017-10-30
Trial ID
NCT03259958
Treatments Being Tested
The study is designed to investigate the safety and efficacy of SB-742457 w...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-07-01
Trial ID
NCT00710684
Treatments Being Tested